Table 2 Baseline characteristics of subjects according to hypertension status in the cohort study
Normotension | Hypertension | P-value* | ||
|---|---|---|---|---|
Baseline Characteristics | N = 419 | N = 324 | N = 95 | |
Gender (male, %) | 123 (38.0) | 41 (43.2) | 0.403 | |
Age (years) | 65 ± 9 | 67 ± 9 | 0.036 | |
BMI (kg/m2) | 21.4 ± 2.6 | 22.5 ± 2.7 | < 0.001 | |
Waist circumference (cm) | 78.0 ± 7.7 | 80.5 ± 7.5 | 0.005 | |
WHtR | 0.50 ± 0.05 | 0.52 ± 0.06 | 0.001 | |
WHpR | 0.87 ± 0.06 | 0.89 ± 0.06 | 0.017 | |
Smoking habit (never/past/light/heavy (%)) | 71.9/15.1/4.6/8.3 | 74.7/12.6/5.3/7.4 | 0.910 | |
Drinking status (never/occasional/light/heavy (%)) | 51.5/25.3/7.1/16.0 | 43.2/25.3/10.5/21.1 | 0.361 | |
Exercise habits (%) | 38.3 | 26.3 | 0.038 | |
Cardiovascular disease (%) | 3.1 | 3.2 | 1.000 | |
Systolic blood pressure (mmHg) | 119 ± 11 | 130 ± 8 | < 0.001 | |
Diastolic blood pressure (mmHg) | 71 ± 8 | 77 ± 7 | < 0.001 | |
Antihypertensive medication (%) | 0 | 0 | 1.000 | |
Triglycerides (mg/dl) | 81 (59–109) | 88 (63–126) | 0.285 | |
HDL cholesterol (mg/dl) | 69 ± 17 | 67 ± 19 | 0.498 | |
LDL cholesterol (mg/dl) | 123 ± 29 | 120 ± 28 | 0.390 | |
Antidyslipidemic medication (%) | 16.0 | 15.8 | 1.000 | |
Hemoglobin A1c (%) | 5.6 (5.4–5.8) | 5.6 (5.4–5.8) | 0.494 | |
Antidiabetic medication (%) | 4.6 | 3.2 | 0.774 | |
Serum uric acid (mg/dL) | 5.0 ± 1.3 | 5.4 ± 1.3 | 0.002 | |
Estimated GFR (ml/min/1.73 m2/year) | 76.0 ± 10.0 | 75.0 ± 8.0 | 0.361 | |